PMC:7543426 / 12550-13688 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T84","span":{"begin":62,"end":66},"obj":"Body_part"},{"id":"T85","span":{"begin":130,"end":140},"obj":"Body_part"},{"id":"T86","span":{"begin":162,"end":170},"obj":"Body_part"},{"id":"T87","span":{"begin":196,"end":204},"obj":"Body_part"},{"id":"T88","span":{"begin":287,"end":292},"obj":"Body_part"},{"id":"T89","span":{"begin":322,"end":330},"obj":"Body_part"},{"id":"T90","span":{"begin":463,"end":468},"obj":"Body_part"},{"id":"T91","span":{"begin":984,"end":992},"obj":"Body_part"},{"id":"T92","span":{"begin":1054,"end":1065},"obj":"Body_part"},{"id":"T93","span":{"begin":1067,"end":1081},"obj":"Body_part"},{"id":"T94","span":{"begin":1108,"end":1118},"obj":"Body_part"}],"attributes":[{"id":"A84","pred":"fma_id","subj":"T84","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A85","pred":"fma_id","subj":"T85","obj":"http://purl.org/sig/ont/fma/fma62499"},{"id":"A86","pred":"fma_id","subj":"T86","obj":"http://purl.org/sig/ont/fma/fma264783"},{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma264783"},{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A89","pred":"fma_id","subj":"T89","obj":"http://purl.org/sig/ont/fma/fma264783"},{"id":"A90","pred":"fma_id","subj":"T90","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A91","pred":"fma_id","subj":"T91","obj":"http://purl.org/sig/ont/fma/fma15844"},{"id":"A92","pred":"fma_id","subj":"T92","obj":"http://purl.org/sig/ont/fma/fma9608"},{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma83555"},{"id":"A94","pred":"fma_id","subj":"T94","obj":"http://purl.org/sig/ont/fma/fma63880"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T55","span":{"begin":62,"end":66},"obj":"Body_part"},{"id":"T56","span":{"begin":1054,"end":1065},"obj":"Body_part"}],"attributes":[{"id":"A55","pred":"uberon_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A56","pred":"uberon_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T123","span":{"begin":107,"end":118},"obj":"Disease"},{"id":"T124","span":{"begin":411,"end":421},"obj":"Disease"},{"id":"T125","span":{"begin":498,"end":509},"obj":"Disease"},{"id":"T126","span":{"begin":531,"end":541},"obj":"Disease"},{"id":"T127","span":{"begin":645,"end":657},"obj":"Disease"},{"id":"T128","span":{"begin":884,"end":902},"obj":"Disease"},{"id":"T129","span":{"begin":1082,"end":1093},"obj":"Disease"}],"attributes":[{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005043"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0018882"},{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0004496"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0018882"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005904"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0000490"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0005043"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T170","span":{"begin":28,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0007919"},{"id":"T171","span":{"begin":28,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0007920"},{"id":"T172","span":{"begin":62,"end":66},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T173","span":{"begin":62,"end":66},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T174","span":{"begin":76,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T175","span":{"begin":142,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T176","span":{"begin":287,"end":292},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T177","span":{"begin":463,"end":468},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T178","span":{"begin":1035,"end":1037},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T179","span":{"begin":1054,"end":1058},"obj":"http://purl.obolibrary.org/obo/UBERON_0002481"},{"id":"T180","span":{"begin":1108,"end":1118},"obj":"http://purl.obolibrary.org/obo/CL_0000136"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"364","span":{"begin":107,"end":140},"obj":"Disease"},{"id":"365","span":{"begin":241,"end":251},"obj":"Disease"},{"id":"366","span":{"begin":322,"end":337},"obj":"Disease"},{"id":"367","span":{"begin":411,"end":421},"obj":"Disease"},{"id":"368","span":{"begin":498,"end":509},"obj":"Disease"},{"id":"369","span":{"begin":531,"end":541},"obj":"Disease"},{"id":"370","span":{"begin":615,"end":623},"obj":"Disease"},{"id":"371","span":{"begin":645,"end":657},"obj":"Disease"},{"id":"372","span":{"begin":687,"end":695},"obj":"Disease"},{"id":"373","span":{"begin":802,"end":811},"obj":"Disease"},{"id":"374","span":{"begin":884,"end":902},"obj":"Disease"},{"id":"375","span":{"begin":937,"end":945},"obj":"Disease"},{"id":"376","span":{"begin":1014,"end":1033},"obj":"Disease"},{"id":"377","span":{"begin":1082,"end":1093},"obj":"Disease"}],"attributes":[{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"MESH:D006965"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:D006470"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D055370"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"MESH:D014657"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"MESH:D009205"},{"id":"A369","pred":"tao:has_database_id","subj":"369","obj":"MESH:D014657"},{"id":"A370","pred":"tao:has_database_id","subj":"370","obj":"MESH:D009336"},{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"MESH:D010493"},{"id":"A372","pred":"tao:has_database_id","subj":"372","obj":"MESH:D005355"},{"id":"A373","pred":"tao:has_database_id","subj":"373","obj":"MESH:D005234"},{"id":"A374","pred":"tao:has_database_id","subj":"374","obj":"MESH:D005921"},{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"MESH:D005355"},{"id":"A376","pred":"tao:has_database_id","subj":"376","obj":"MESH:D008224"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"MESH:D006965"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T50","span":{"begin":314,"end":337},"obj":"Phenotype"},{"id":"T51","span":{"begin":411,"end":421},"obj":"Phenotype"},{"id":"T52","span":{"begin":498,"end":509},"obj":"Phenotype"},{"id":"T53","span":{"begin":531,"end":541},"obj":"Phenotype"},{"id":"T54","span":{"begin":645,"end":657},"obj":"Phenotype"},{"id":"T55","span":{"begin":802,"end":811},"obj":"Phenotype"},{"id":"T56","span":{"begin":884,"end":902},"obj":"Phenotype"}],"attributes":[{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0033006"},{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0002633"},{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0012819"},{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0002633"},{"id":"A54","pred":"hp_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/HP_0001701"},{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0001397"},{"id":"A56","pred":"hp_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/HP_0000096"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T7","span":{"begin":615,"end":623},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T8","span":{"begin":615,"end":623},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T9","span":{"begin":615,"end":623},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T10","span":{"begin":615,"end":623},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T138","span":{"begin":0,"end":61},"obj":"Sentence"},{"id":"T139","span":{"begin":62,"end":66},"obj":"Sentence"},{"id":"T140","span":{"begin":67,"end":105},"obj":"Sentence"},{"id":"T141","span":{"begin":106,"end":160},"obj":"Sentence"},{"id":"T142","span":{"begin":161,"end":194},"obj":"Sentence"},{"id":"T143","span":{"begin":195,"end":239},"obj":"Sentence"},{"id":"T144","span":{"begin":240,"end":272},"obj":"Sentence"},{"id":"T145","span":{"begin":273,"end":312},"obj":"Sentence"},{"id":"T146","span":{"begin":313,"end":374},"obj":"Sentence"},{"id":"T147","span":{"begin":375,"end":409},"obj":"Sentence"},{"id":"T148","span":{"begin":410,"end":440},"obj":"Sentence"},{"id":"T149","span":{"begin":441,"end":488},"obj":"Sentence"},{"id":"T150","span":{"begin":489,"end":496},"obj":"Sentence"},{"id":"T151","span":{"begin":497,"end":529},"obj":"Sentence"},{"id":"T152","span":{"begin":530,"end":561},"obj":"Sentence"},{"id":"T153","span":{"begin":562,"end":607},"obj":"Sentence"},{"id":"T154","span":{"begin":608,"end":643},"obj":"Sentence"},{"id":"T155","span":{"begin":644,"end":676},"obj":"Sentence"},{"id":"T156","span":{"begin":677,"end":715},"obj":"Sentence"},{"id":"T157","span":{"begin":716,"end":723},"obj":"Sentence"},{"id":"T158","span":{"begin":724,"end":768},"obj":"Sentence"},{"id":"T159","span":{"begin":769,"end":800},"obj":"Sentence"},{"id":"T160","span":{"begin":801,"end":831},"obj":"Sentence"},{"id":"T161","span":{"begin":832,"end":837},"obj":"Sentence"},{"id":"T162","span":{"begin":838,"end":882},"obj":"Sentence"},{"id":"T163","span":{"begin":883,"end":922},"obj":"Sentence"},{"id":"T164","span":{"begin":923,"end":964},"obj":"Sentence"},{"id":"T165","span":{"begin":965,"end":972},"obj":"Sentence"},{"id":"T166","span":{"begin":973,"end":1012},"obj":"Sentence"},{"id":"T167","span":{"begin":1013,"end":1053},"obj":"Sentence"},{"id":"T168","span":{"begin":1054,"end":1065},"obj":"Sentence"},{"id":"T169","span":{"begin":1066,"end":1106},"obj":"Sentence"},{"id":"T170","span":{"begin":1107,"end":1138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Findings Group 1, No. (%) (n = 18) Group 2, No. (%) (n = 4)\nLung\n Hyaline membranes 8 (44.4) 2 (50.0)\n Hyperplasia of type II pneumocyte 11 (61.2) 4 (100)\n Alveolar plug 8 (44.4) 4 (100)\n Alveolar fibrin deposit 9 (50.0) 3 (75.0)\n Hemorrhage 10 (55.6) 2 (50.0)\n Inflammatory cells 13 (72.3) 4 (100)\n Diffuse alveolar damage, fibrotic phase 12 (66.7) 1 (25.0)\n Microthrombi 14 (77.8) 2 (50.0)\n Vasculitis 8 (44.4) 4 (100)\n Multinucleated giant cells 4 (22.3) 2 (50.0)\nCardiac\n Myocarditis 9 (50.0) 3 (75.0)\n Vasculitis 5 (27.8) 3 (75.0)\n Inflammatory infiltrate 13 (72.3) 3 (75.0)\n Focal necrosis 6 (33.4) 2 (50.0)\n Pericarditis 9 (50.0) 4 (100)\n Vascular fibrosis 4 (22.3) 2 (50.0)\nHepatic\n Inflammatory infiltrate 8 (44.4) 3 (75.0)\n Congestion 8 (44.4) 2 (50.0)\n Steatosis 9 (50.0) 3 (75.0)\nRenal\n Inflammatory infiltrate 9 (50.0) 3 (75.0)\n Glomerulosclerosis 9 (50.0) 3 (75.0)\n Interstitial fibrosis 9 (50.0) 4 (100)\nSplenic\n Congested red pulp 15 (83.4) 4 (100)\n Lymphoid hypoplasia 11 (61.2) 4 (100)\nBone marrow\n Megakaryocytes hyperplasia 0 2 (50.0)\n Adipocytes 7 (38.9) 1 (25.0)"}